Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001610717-23-000405 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-12-19 | 2023-12-15 | IDYA | Hata Yujiro S | Pres, CEO, Dir | M - OptEx | $4.31 | +75.0K | 752.9K | +11% | +$323.2K |
| DT | 2023-12-19 | 2023-12-15 | IDYA | Hata Yujiro S | Pres, CEO, Dir | S - Sale+OE | $35.03 | -75.0K | 677.9K | -10% | -$2.63M |
| DT | 2023-12-19 | 2023-12-15 | IDYA | Hata Yujiro S | Pres, CEO, Dir | M - OptEx | $0.00 | -75.0K | 399.5K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | M | A | 75,000 | $4.31 | 752,887 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-15 | S | D | 75,000 | $35.03 | 677,887 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $35.00 to $35.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-15 | M | D | 75,000 | $0.00 | 399,454 | D | $4.31 · — to 2028-02-26 | 75,000 Common Stock | (F3) The shares subject to the option are fully vested and exercisable. |